Extracellular matrix biomaterials

Patent Pending ECM biomaterials are a class of biomaterials derived from processing human or animal tissues to retain portions of the extracellular matrix. These materials are typically cell-free, distinguishing them from classical allografts and xenografts, can be integrated or incorporated into the body, and have been FDA approved for human use for more than 10 years in a wide range of clinical indications.